Carregant...
Antiviral applications of RNAi for coronavirus
Until the appearance of severe acute respiratory syndrome (SARS), caused by the SARS coronavirus (SARS-CoV) in early 2003, coronavirus infection was not considered to be serious enough to be controlled by either vaccination or specific antiviral therapy. It is now believed that the availability of a...
Guardat en:
| Publicat a: | Expert Opin Investig Drugs |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103689/ https://ncbi.nlm.nih.gov/pubmed/16433589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.15.2.89 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|